|
US4452773A
(en)
|
1982-04-05 |
1984-06-05 |
Canadian Patents And Development Limited |
Magnetic iron-dextran microspheres
|
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
|
US4690915A
(en)
|
1985-08-08 |
1987-09-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adoptive immunotherapy as a treatment modality in humans
|
|
US4795698A
(en)
|
1985-10-04 |
1989-01-03 |
Immunicon Corporation |
Magnetic-polymer particles
|
|
IN165717B
(enExample)
|
1986-08-07 |
1989-12-23 |
Battelle Memorial Institute |
|
|
US5219740A
(en)
|
1987-02-13 |
1993-06-15 |
Fred Hutchinson Cancer Research Center |
Retroviral gene transfer into diploid fibroblasts for gene therapy
|
|
ES2067018T3
(es)
|
1988-12-28 |
1995-03-16 |
Stefan Miltenyi |
Procedimiento y materiales para la separacion en alto gradiente magnetico de materiales biologicos.
|
|
US5200084A
(en)
|
1990-09-26 |
1993-04-06 |
Immunicon Corporation |
Apparatus and methods for magnetic separation
|
|
US5827642A
(en)
|
1994-08-31 |
1998-10-27 |
Fred Hutchinson Cancer Research Center |
Rapid expansion method ("REM") for in vitro propagation of T lymphocytes
|
|
WO1996013593A2
(en)
|
1994-10-26 |
1996-05-09 |
Procept, Inc. |
Soluble single chain t cell receptors
|
|
WO1996018105A1
(en)
|
1994-12-06 |
1996-06-13 |
The President And Fellows Of Harvard College |
Single chain t-cell receptor
|
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
|
US5773224A
(en)
|
1996-02-12 |
1998-06-30 |
Grandics; Peter |
Immunoselection system for cell elution
|
|
DE19608753C1
(de)
|
1996-03-06 |
1997-06-26 |
Medigene Gmbh |
Transduktionssystem und seine Verwendung
|
|
WO1997034634A1
(en)
|
1996-03-20 |
1997-09-25 |
Sloan-Kettering Institute For Cancer Research |
Single chain fv constructs of anti-ganglioside gd2 antibodies
|
|
AU6467796A
(en)
|
1996-04-24 |
1997-05-15 |
Claude Fell |
Cell separation system for biological fluids like blood
|
|
EP0973928B1
(en)
|
1997-03-11 |
2010-05-05 |
Regents Of The University Of Minnesota |
Dna-based transposon system for the introduction of nucleic acid into dna of a cell
|
|
JP2001519143A
(ja)
|
1997-10-02 |
2001-10-23 |
スノル・モレキュラー・コーポレーション |
可溶性の一本鎖ｔ細胞レセプタータンパク質
|
|
WO1999025817A2
(en)
|
1997-11-13 |
1999-05-27 |
Regents Of The University Of Minnesota |
Tc1-based transposon vectors
|
|
US5994136A
(en)
|
1997-12-12 |
1999-11-30 |
Cell Genesys, Inc. |
Method and means for producing high titer, safe, recombinant lentivirus vectors
|
|
BR9910253A
(pt)
|
1998-05-19 |
2002-09-17 |
Avidex Ltd |
Receptor de célula t solúvel
|
|
WO2000014257A1
(en)
|
1998-09-04 |
2000-03-16 |
Sloan-Kettering Institute For Cancer Research |
Fusion receptors specific for prostate-specific membrane antigen and uses thereof
|
|
AU2472400A
(en)
|
1998-10-20 |
2000-05-08 |
City Of Hope |
CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies
|
|
CN1182882C
(zh)
|
1998-12-24 |
2005-01-05 |
生物安全股份有限公司 |
特别用于浓缩造血干细胞的血液分离系统
|
|
US6664042B1
(en)
|
1999-01-26 |
2003-12-16 |
Cornell Research Foundation, Inc. |
Determining viral load in double negative T cells
|
|
CA2410510A1
(en)
|
2000-06-02 |
2001-12-13 |
Memorial Sloan-Kettering Cancer Center |
Artificial antigen presenting cells and methods of use thereof
|
|
AU2001297703B2
(en)
|
2000-11-07 |
2006-10-19 |
City Of Hope |
CD19-specific redirected immune cells
|
|
US7070995B2
(en)
|
2001-04-11 |
2006-07-04 |
City Of Hope |
CE7-specific redirected immune cells
|
|
US20090257994A1
(en)
|
2001-04-30 |
2009-10-15 |
City Of Hope |
Chimeric immunoreceptor useful in treating human cancers
|
|
MXPA04001974A
(es)
|
2001-08-31 |
2004-07-16 |
Avidex Ltd |
Receptor de celula t soluble.
|
|
US7939059B2
(en)
|
2001-12-10 |
2011-05-10 |
California Institute Of Technology |
Method for the generation of antigen-specific lymphocytes
|
|
US20030170238A1
(en)
|
2002-03-07 |
2003-09-11 |
Gruenberg Micheal L. |
Re-activated T-cells for adoptive immunotherapy
|
|
US7446190B2
(en)
|
2002-05-28 |
2008-11-04 |
Sloan-Kettering Institute For Cancer Research |
Nucleic acids encoding chimeric T cell receptors
|
|
CA2500392C
(en)
|
2002-09-27 |
2012-11-27 |
The General Hospital Corporation |
Microfluidic device for cell separation and uses thereof
|
|
NZ539225A
(en)
|
2002-10-09 |
2006-09-29 |
Avidex Ltd |
Single chain recombinant T cell receptors
|
|
US20050129671A1
(en)
|
2003-03-11 |
2005-06-16 |
City Of Hope |
Mammalian antigen-presenting T cells and bi-specific T cells
|
|
WO2004096975A2
(en)
|
2003-05-02 |
2004-11-11 |
Insception Bioscience, Inc. |
Apparatus and methods for amplification of blood stem cell numbers
|
|
US20050025763A1
(en)
|
2003-05-08 |
2005-02-03 |
Protein Design Laboratories, Inc. |
Therapeutic use of anti-CS1 antibodies
|
|
EP1631788B1
(en)
|
2003-05-16 |
2007-03-14 |
Universite Libre De Bruxelles |
Digital holographic microscope for 3d imaging and process using it
|
|
AU2005235811B2
(en)
|
2004-02-06 |
2011-11-03 |
Morphosys Ag |
Anti-CD38 human antibodies and uses therefor
|
|
JP5563194B2
(ja)
|
2004-06-29 |
2014-07-30 |
イムノコア リミテッド |
改変ｔ細胞レセプターを発現する細胞
|
|
ES2345837T3
(es)
|
2005-03-23 |
2010-10-04 |
Biosafe S.A. |
Sistema integrado para la recogida, el procesamiento y el trasplante de subgrupos de celulas, incluyendo celulas madre adultas, para medicina regenerativa.
|
|
EP3312196B1
(en)
|
2005-03-23 |
2019-07-17 |
Genmab A/S |
Antibodies against cd38 for treatment of multiple myeloma
|
|
WO2007117602A2
(en)
|
2006-04-07 |
2007-10-18 |
Biogen Idec Ma Inc. |
Isolation and use of human regulatory t cells
|
|
US20080085532A1
(en)
|
2006-09-18 |
2008-04-10 |
Jorn Gorlach |
Method for determining the immune status of a subject
|
|
WO2008035631A1
(fr)
|
2006-09-20 |
2008-03-27 |
Kyowa Hakko Kogyo Co., Ltd. |
Procédé de production d'une substance
|
|
EP1914242A1
(en)
|
2006-10-19 |
2008-04-23 |
Sanofi-Aventis |
Novel anti-CD38 antibodies for the treatment of cancer
|
|
PL2856876T3
(pl)
|
2007-03-30 |
2018-06-29 |
Memorial Sloan-Kettering Cancer Center |
Konstytutywna ekspresja ligandów kostymulujących na limfocytach T poddanych transferowi adoptywnemu
|
|
EP2167537A2
(en)
|
2007-07-03 |
2010-03-31 |
Dako Denmark A/S |
Compiled methods for analysing and sorting samples
|
|
ES2640216T3
(es)
|
2007-12-07 |
2017-11-02 |
Miltenyi Biotec Gmbh |
Sistemas y métodos para procesamiento de células
|
|
US8479118B2
(en)
|
2007-12-10 |
2013-07-02 |
Microsoft Corporation |
Switching search providers within a browser search box
|
|
TR201802323T4
(tr)
|
2007-12-11 |
2018-03-21 |
Univ North Carolina Chapel Hill |
Polipürin yolu modifiye edilmiş retroviral vektörler.
|
|
HRP20140604T1
(hr)
|
2007-12-26 |
2014-09-12 |
Biotest Ag |
Sredstva koja djeluju na cd138 i njihova upotreba
|
|
JP5484677B2
(ja)
|
2008-01-18 |
2014-05-07 |
三菱重工業株式会社 |
脱水装置
|
|
JP5173594B2
(ja)
|
2008-05-27 |
2013-04-03 |
キヤノン株式会社 |
管理装置、画像形成装置及びそれらの処理方法
|
|
US8822647B2
(en)
|
2008-08-26 |
2014-09-02 |
City Of Hope |
Method and compositions using a chimeric antigen receptor for enhanced anti-tumor effector functioning of T cells
|
|
WO2010051391A1
(en)
|
2008-10-31 |
2010-05-06 |
Facet Biotech Corporation |
Use of anti-cs1 antibodies for treatment of rare lymphomas
|
|
CA2757382A1
(en)
|
2009-04-01 |
2010-10-21 |
Kristi Elkins |
Anti-fcrh5 antibodies and immunoconjugates
|
|
US20110070581A1
(en)
|
2009-04-27 |
2011-03-24 |
Amit Gupta |
Separation of Leukocytes
|
|
EP2486049A1
(en)
|
2009-10-06 |
2012-08-15 |
The Board Of Trustees Of The UniversityOf Illinois |
Human single-chain t cell receptors
|
|
ES2717629T3
(es)
|
2009-11-03 |
2019-06-24 |
Hope City |
Receptor del factor de crecimiento epidérmico truncado (EGFRt) para selección de células T transducidas
|
|
US20110293667A1
(en)
|
2010-01-14 |
2011-12-01 |
Dolores Baksh |
Bioengineered Tissue Constructs and Methods for Producing and Using Thereof
|
|
US9511151B2
(en)
|
2010-11-12 |
2016-12-06 |
Uti Limited Partnership |
Compositions and methods for the prevention and treatment of cancer
|
|
PH12013501201A1
(en)
|
2010-12-09 |
2013-07-29 |
Univ Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
|
CN103458904B
(zh)
*
|
2010-12-16 |
2016-09-28 |
株式会社明治 |
格氏乳杆菌的菌体级分在制造用于减轻迟发型变态反应的组合物中的用途
|
|
JOP20210044A1
(ar)
|
2010-12-30 |
2017-06-16 |
Takeda Pharmaceuticals Co |
الأجسام المضادة لـ cd38
|
|
US9987308B2
(en)
|
2011-03-23 |
2018-06-05 |
Fred Hutchinson Cancer Research Center |
Method and compositions for cellular immunotherapy
|
|
US8398282B2
(en)
|
2011-05-12 |
2013-03-19 |
Delphi Technologies, Inc. |
Vehicle front lighting assembly and systems having a variable tint electrowetting element
|
|
EP2717561B1
(en)
|
2011-05-24 |
2019-03-27 |
Sony Semiconductor Solutions Corporation |
Solid-state imaging element and camera system
|
|
KR101662412B1
(ko)
|
2011-07-01 |
2016-10-04 |
암젠 인크 |
포유동물 세포 배양
|
|
US9023604B2
(en)
|
2011-07-18 |
2015-05-05 |
Iba Gmbh |
Method of reversibly staining a target cell
|
|
US9684281B2
(en)
|
2011-07-19 |
2017-06-20 |
Ovizio Imaging Systems NV/SA |
Method and system for detecting and/or classifying cancerous cells in a cell sample
|
|
WO2013038272A2
(en)
|
2011-09-13 |
2013-03-21 |
Uti Limited Partnership |
Streptavidin mutein exhibiting reversible binding for biotin and streptavidin binding peptide tagged proteins
|
|
WO2013062365A2
(ko)
|
2011-10-26 |
2013-05-02 |
국립암센터 |
변이 ｃｔｌａ4 유전자 이입 ｔ 세포 및 이를 포함하는 항암 면역치료용 조성물
|
|
US10208086B2
(en)
|
2011-11-11 |
2019-02-19 |
Fred Hutchinson Cancer Research Center |
Cyclin A1-targeted T-cell immunotherapy for cancer
|
|
US8497124B2
(en)
|
2011-12-05 |
2013-07-30 |
Factor Bioscience Inc. |
Methods and products for reprogramming cells to a less differentiated state
|
|
EP3594245A1
(en)
|
2012-02-13 |
2020-01-15 |
Seattle Children's Hospital d/b/a Seattle Children's Research Institute |
Bispecific chimeric antigen receptors and therapeutic uses thereof
|
|
WO2013126726A1
(en)
|
2012-02-22 |
2013-08-29 |
The Trustees Of The University Of Pennsylvania |
Double transgenic t cells comprising a car and a tcr and their methods of use
|
|
JP6362543B2
(ja)
|
2012-02-23 |
2018-07-25 |
ジュノ セラピューティクス ゲーエムベーハー |
細胞および他の複雑な生物学的材料のクロマトグラフィーによる単離
|
|
CN107557334B
(zh)
|
2012-05-03 |
2021-06-25 |
弗雷德哈钦森癌症研究中心 |
增强亲和力的t细胞受体及其制备方法
|
|
LT3338794T
(lt)
|
2012-07-13 |
2020-05-25 |
The Trustees Of The University Of Pennsylvania |
Car priešnavikinio aktyvumo toksiškumo reguliavimas
|
|
CN112375846A
(zh)
|
2012-07-13 |
2021-02-19 |
宾夕法尼亚大学董事会 |
评估用于施用的转导t细胞的适用性的方法
|
|
PL3824905T3
(pl)
|
2012-08-20 |
2025-05-05 |
Fred Hutchinson Cancer Center |
Sposób i kompozycje do immunoterapii komórkowej
|
|
WO2014044823A1
(en)
|
2012-09-20 |
2014-03-27 |
Ovizio Imaging Systems NV/SA |
Digital holographic microscope with fluid systems
|
|
SG11201502598SA
(en)
|
2012-10-02 |
2015-05-28 |
Sloan Kettering Inst Cancer |
Compositions and methods for immunotherapy
|
|
TWI654206B
(zh)
|
2013-03-16 |
2019-03-21 |
諾華公司 |
使用人類化抗－ｃｄ１９嵌合抗原受體治療癌症
|
|
CN103305464B
(zh)
|
2013-06-05 |
2015-04-15 |
南昌大学 |
直接分离cd4+和cd8+淋巴细胞的方法
|
|
TWI725931B
(zh)
|
2013-06-24 |
2021-05-01 |
美商建南德克公司 |
抗ｆｃｒｈ５抗體
|
|
AU2014368892B2
(en)
|
2013-12-20 |
2019-06-13 |
Fred Hutchinson Cancer Center |
Tagged chimeric effector molecules and receptors thereof
|
|
IL322264A
(en)
|
2014-04-07 |
2025-09-01 |
Novartis Ag |
Cancer treatment using chimeric antigen receptor (CAR) against CD19
|
|
AU2015243849B2
(en)
|
2014-04-10 |
2020-12-17 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Transgene genetic tags and methods of use
|
|
LT3132247T
(lt)
|
2014-04-16 |
2021-12-10 |
Juno Therapeutics Gmbh |
Ląstelių populiacijos padauginimo būdai, rinkiniai ir priemonės
|
|
IL313845A
(en)
|
2014-04-23 |
2024-08-01 |
Juno Therapeutics Inc |
Methods for enriching or producing immune cell populations for adoptive therapy
|
|
EP3738597A1
(en)
|
2014-04-25 |
2020-11-18 |
Bluebird Bio, Inc. |
Improved methods for manufacturing adoptive cell therapies
|
|
WO2015181253A1
(en)
|
2014-05-27 |
2015-12-03 |
Fundación Pública Andaluza Progreso Y Salud |
Neural progenitor cell population
|
|
MY181834A
(en)
|
2014-07-21 |
2021-01-08 |
Novartis Ag |
Treatment of cancer using humanized anti-bcma chimeric antigen receptor
|
|
US20170209492A1
(en)
|
2014-07-31 |
2017-07-27 |
Novartis Ag |
Subset-optimized chimeric antigen receptor-containing t-cells
|
|
SG11201700770PA
(en)
|
2014-08-19 |
2017-03-30 |
Novartis Ag |
Anti-cd123 chimeric antigen receptor (car) for use in cancer treatment
|
|
TWI805109B
(zh)
|
2014-08-28 |
2023-06-11 |
美商奇諾治療有限公司 |
對cd19具專一性之抗體及嵌合抗原受體
|
|
CN117427091A
(zh)
|
2014-10-20 |
2024-01-23 |
朱诺治疗学股份有限公司 |
用于过继细胞治疗中的给药的组合物和方法
|
|
CN113736828A
(zh)
*
|
2014-11-05 |
2021-12-03 |
朱诺治疗学股份有限公司 |
用于转导及细胞处理的方法
|
|
WO2016090190A1
(en)
|
2014-12-03 |
2016-06-09 |
Juno Therapeutics, Inc. |
Methods and compositions for adoptive cell therapy
|
|
CN113968912B
(zh)
|
2014-12-05 |
2025-05-16 |
纪念斯隆-凯特琳癌症中心 |
靶向g-蛋白偶联受体的嵌合抗原受体及其用途
|
|
CN104450614B
(zh)
|
2014-12-05 |
2017-07-07 |
上海安集协康生物技术股份有限公司 |
一种无动物蛋白源的免疫细胞无血清培养基及其使用方法
|
|
CA2969704C
(en)
*
|
2014-12-05 |
2023-05-02 |
City Of Hope |
Cs1 targeted chimeric antigen receptor-modified t cells
|
|
EP3872094A3
(en)
|
2014-12-05 |
2021-12-08 |
Memorial Sloan Kettering Cancer Center |
Antibodies targeting b-cell maturation antigen and methods of use
|
|
KR102602417B1
(ko)
|
2014-12-05 |
2023-11-16 |
메모리얼 슬로안 케터링 캔서 센터 |
G-단백질 커플화 수용체를 표적화하는 항체 및 이의 사용 방법
|
|
SG11201704549UA
(en)
|
2014-12-05 |
2017-07-28 |
Memorial Sloan Kettering Cancer Center |
Chimeric antigen receptors targeting b-cell maturation antigen and uses thereof
|
|
EP3280795B1
(en)
|
2015-04-07 |
2021-03-24 |
Novartis AG |
Combination of chimeric antigen receptor therapy and amino pyrimidine derivatives
|
|
MX2017012939A
(es)
|
2015-04-08 |
2018-05-22 |
Novartis Ag |
Terapias cd20, terapias cd22 y terapias de combinacion con una celula que expresa un receptor quimerico de antigeno (car) de cd19.
|
|
EP3286225B1
(en)
|
2015-04-23 |
2020-07-01 |
Baylor College of Medicine |
Cd5 chimeric antigen receptor for adoptive t cell therapy
|
|
IL255887B
(en)
|
2015-05-28 |
2022-09-01 |
Kite Pharma Inc |
Methods for training patients for t-cell therapy
|
|
CN107921064A
(zh)
|
2015-05-28 |
2018-04-17 |
凯德药业股份有限公司 |
用于t细胞疗法的诊断方法
|
|
AU2016297605A1
(en)
*
|
2015-07-21 |
2018-02-15 |
City Of Hope |
T cells for expression of chimeric antigen receptors and other receptors
|
|
WO2017015427A1
(en)
*
|
2015-07-21 |
2017-01-26 |
Novartis Ag |
Methods for improving the efficacy and expansion of immune cells
|
|
CN108025024B
(zh)
|
2015-07-28 |
2022-11-29 |
宾夕法尼亚大学董事会 |
表达嵌合抗原受体的修饰单核细胞/巨噬细胞及其用途
|
|
GB2557123B
(en)
*
|
2015-07-31 |
2021-11-03 |
Univ Minnesota |
Modified cells and methods of therapy
|
|
JP7162530B2
(ja)
*
|
2015-08-07 |
2022-10-28 |
シアトル チルドレンズ ホスピタル （ディービーエイ シアトル チルドレンズ リサーチ インスティテュート） |
固形腫瘍を標的とする二重特異性ｃａｒ ｔ細胞
|
|
WO2017035362A1
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Use of complement pathway inhibitor compounds to mitigate adoptive t-cell therapy associated adverse immune responses
|
|
HK1250517A1
(zh)
|
2015-09-17 |
2018-12-21 |
Novartis Ag |
增强功效的car t细胞疗法
|
|
KR20180053744A
(ko)
|
2015-09-23 |
2018-05-23 |
사이토이뮨 테라퓨틱스 엘엘씨 |
면역 요법을 위한 flt3 유도된 car 세포
|
|
WO2017058850A1
(en)
|
2015-09-28 |
2017-04-06 |
Regents Of The University Of Minnesota |
Chimeric antigen receptor (car) t cells as therapeutic interventions for auto- and allo-immunity
|
|
US11466253B2
(en)
|
2015-10-22 |
2022-10-11 |
Juno Therapeutics Gmbh |
Methods for culturing cells and kits and apparatus for same
|
|
CN108884140B
(zh)
|
2015-12-03 |
2022-10-25 |
朱诺治疗学股份有限公司 |
修饰的嵌合受体及相关组合物和方法
|
|
WO2017156479A1
(en)
|
2016-03-11 |
2017-09-14 |
Bluebird Bio, Inc. |
Ror1 chimeric antigen receptors
|
|
CN108779242B
(zh)
*
|
2016-03-17 |
2021-06-11 |
默克专利股份公司 |
纯化泊洛沙姆的方法
|
|
WO2017161353A1
(en)
|
2016-03-18 |
2017-09-21 |
Fred Hutchinson Cancer Researh Center |
Compositions and methods for cd20 immunotherapy
|
|
CA3020330A1
(en)
|
2016-04-07 |
2017-10-12 |
Bluebird Bio, Inc. |
Chimeric antigen receptor t cell compositions
|
|
MX2018014911A
(es)
|
2016-06-06 |
2019-08-12 |
Juno Therapeutics Inc |
Metodos para el tratamiento de afecciones malignas de celulas t usando terapia de celulas adoptivas.
|
|
CN106754670B
(zh)
|
2016-11-30 |
2020-02-14 |
湖南省生宝生物科技有限公司 |
一种间充质干细胞无血清培养基及其配制方法和应用
|
|
MA46998A
(fr)
|
2016-12-05 |
2019-10-09 |
Juno Therapeutics Inc |
Production de cellules modifiées pour une thérapie cellulaire adoptive
|
|
CN106635955B
(zh)
|
2016-12-16 |
2020-05-19 |
江苏艾尔康生物医药科技有限公司 |
类角膜内皮细胞的获取方法
|
|
CN106834218B
(zh)
|
2017-01-06 |
2021-03-02 |
沈阳艾米奥生物工程技术研发中心有限公司 |
人羊膜上皮干细胞无血清培养基及其培养方法
|
|
CN106801032B
(zh)
|
2017-02-17 |
2021-03-02 |
沈阳艾米奥生物工程技术研发中心有限公司 |
人羊膜上皮干细胞库的构建方法
|
|
CA3053539A1
(en)
|
2017-02-27 |
2018-08-30 |
Juno Therapeutics, Inc. |
Compositions, articles of manufacture and methods related to dosing in cell therapy
|
|
ES2724434T3
(es)
|
2017-03-09 |
2019-09-10 |
Evonik Technochemie Gmbh |
Medios de cultivo que comprenden dipéptidos de N-acil-X-glutamina
|
|
CN110709700A
(zh)
*
|
2017-04-14 |
2020-01-17 |
朱诺治疗学股份有限公司 |
评估细胞表面糖基化的方法
|
|
CN111225675B
(zh)
|
2017-06-02 |
2024-05-03 |
朱诺治疗学股份有限公司 |
使用过继细胞疗法治疗的制品和方法
|
|
CA3070575A1
(en)
|
2017-08-09 |
2019-02-14 |
Juno Therapeutics, Inc. |
Methods and compositions for preparing genetically engineered cells
|
|
AU2018313950A1
(en)
|
2017-08-09 |
2020-02-13 |
Juno Therapeutics, Inc. |
Methods for producing genetically engineered cell compositions and related compositions
|
|
KR20200116081A
(ko)
|
2017-12-01 |
2020-10-08 |
주노 쎄러퓨티크스 인코퍼레이티드 |
유전자 조작된 세포의 투약 및 조절 방법
|
|
JP7433230B2
(ja)
|
2017-12-08 |
2024-02-19 |
ジュノー セラピューティクス インコーポレイテッド |
細胞を培養するための無血清培地配合物およびその使用の方法
|
|
CA3084445A1
(en)
*
|
2017-12-08 |
2019-06-13 |
Juno Therapeutics, Inc. |
Process for producing a composition of engineered t cells
|
|
EP3775238A1
(en)
|
2018-04-05 |
2021-02-17 |
Juno Therapeutics, Inc. |
Methods of producing cells expressing a recombinant receptor and related compositions
|
|
JP7410877B2
(ja)
|
2018-05-03 |
2024-01-10 |
ジュノー セラピューティクス インコーポレイテッド |
キメラ抗原受容体（ｃａｒ）ｔ細胞療法とキナーゼ阻害剤の併用療法
|
|
SG11202101204TA
(en)
|
2018-08-09 |
2021-03-30 |
Juno Therapeutics Inc |
Processes for generating engineered cells and compositions thereof
|
|
EP3880238A1
(en)
|
2018-11-16 |
2021-09-22 |
Juno Therapeutics, Inc. |
Methods of dosing engineered t cells for the treatment of b cell malignancies
|
|
BR112021010354A2
(pt)
|
2018-11-30 |
2021-11-03 |
Juno Therapeutics Inc |
Métodos para o tratamento usando terapia celular adotiva
|
|
SG11202105380RA
(en)
|
2018-11-30 |
2021-06-29 |
Juno Therapeutics Inc |
Methods for dosing and treatment of b cell malignancies in adoptive cell therapy
|
|
KR20220145341A
(ko)
|
2020-01-24 |
2022-10-28 |
주노 쎄러퓨티크스 인코퍼레이티드 |
입양 세포 요법에서 여포성 림프종 및 변연부 림프종의 투여 및 치료 방법
|
|
KR20220146480A
(ko)
|
2020-01-28 |
2022-11-01 |
주노 쎄러퓨티크스 인코퍼레이티드 |
Ｔ 세포 형질도입 방법
|